SecBot SecBot
EFFECT ·Filed Jun 12, 2026

SCLX

Scilex Holding Co
BEARISH
Impact 6/10
Horizonweeks Processed5mo ago SEC9999999995-26-001971
IPO/offering going effective
Actionable Insight ▼ Bearish

The shelf effectiveness formalizes existing dilution overhang but does not create new immediate selling pressure. Monitor for any subsequent takedown notice or registration of new shares at lower prices, which would signal active dilution. The going concern opinion and minimal cash proceeds expectation suggest the company may need alternative financing soon.

DirectionBearish
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$8.50
T+0 close · Jun 12, 2026 · via day close
Latest settled
−1.75%
T+60 · $8.35
Vs SPY
−4.53%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 12 $8.50entry
  2. T+1 · 5mo ago −6.47%α −8.23% · $7.95
  3. T+5 · 5mo ago +29.80%α +29.45% · $11.03
  4. T+20 · 4mo ago +65.51%α +64.15% · $14.07
  5. T+60 · 2mo ago −1.75%α −4.53% · $8.35
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Scilex Holding Co's S-3 shelf registration (File No. 333-296430) became effective on June 11, 2026. This allows the company to sell up to 2,083,067 primary shares issuable upon exercise of outstanding warrants and conversion of convertible notes, plus up to 6,581,004 resale shares and 490,617 warrants held by selling securityholders. The effectiveness activates a dilution overhang, though warrant exercise prices far exceed the current stock price, making cash exercise unlikely.

Key Facts

  • S-3 shelf registration (File No. 333-296430) declared effective on June 11, 2026.
  • Registration covers up to 2,083,067 primary shares issuable upon exercise of warrants and conversion of convertible notes.
  • Registration also covers up to 6,581,004 resale shares and 490,617 warrants held by selling securityholders.
  • Warrant exercise prices range from $22.72 to $402.50, far above the stock's recent close of $7.99 (as of June 1, 2026).
  • Company expects little to no cash proceeds from warrant exercises.
  • Cross-filing context includes a going concern audit opinion and a complex capital structure with heavy dilution overhang.

Financial Impact

Potential dilution from up to 8.66 million shares (primary + resale) on a market cap of $74M, but cash proceeds expected to be minimal due to out-of-the-money warrants.

dilutionshare countcapital structure

Risk Factors

  • Potential for active share issuance if the company finds a buyer at current depressed prices.
  • Going concern audit opinion indicates risk of insolvency without additional capital.
  • Warrant overhang may cap any upside rally as holders could sell into strength.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-001971
Document: 9999999995-26-001971-index.html9999999995-26-001971
Document: 9999999995-26-001971.txt9999999995-26-001971

Track record

11 reports on SCLX

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +34.62% at T+60 after the Jun 29, 2026 report. 2 of 3 went positive at some point.

Filters
  1. Jul 22, 202616w ago 8-K Mixed 5/10 Entry $7.39 to $2.82 Now $1.25 −83.09% ▼ −61.84% −66.39% vs SPY
  2. Jul 6, 202619w ago 8-K Mixed 6/10 Entry $8.07 to $4.41 Now $1.25 −84.51% ▼ −45.35% −47.07% vs SPY
  3. Jun 29, 202620w ago 8-K Bearish 7/10 Entry $7.80 to $5.10 Now $1.25 +83.97% ▲ +34.62% +37.43% vs SPY
  4. Jun 12, 202622w ago Press Release Neutral 2/10 Entry $8.50 to $8.35 Now $1.25 −85.29% ▼ −1.75% −4.53% vs SPY
  5. Jun 12, 202622w ago EFFECT Bearish 6/10 Viewing Entry $8.50 to $8.35 Now $1.25 +85.29% ▲ +1.75% +4.53% vs SPY
  6. Jun 11, 202622w ago Institutional Cluster Neutral 2/10 Entry $8.70 to $8.62 Now $1.25 −85.63% ▼ −0.87% −4.69% vs SPY
  7. Jun 4, 202623w ago Press Release Neutral 4/10 Entry $4.72 to $5.43 Now $1.25 −73.52% ▲ +15.05% +13.17% vs SPY
  8. May 5, 202627w ago Press Release Bullish 8/10 Entry $6.68 to $6.60 Now $1.25 −81.29% ▼ −1.22% −3.96% vs SPY
  9. May 4, 202628w ago Press Release Neutral 4/10 Entry $6.94 to $6.56 Now $1.25 −82.00% ▼ −5.51% −7.37% vs SPY
  10. Apr 17, 202630w ago Insider Cluster Mixed 6/10 Entry $4.30 to $8.76 Now $1.25 −70.91% ▲ +103.89% +97.75% vs SPY
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 47m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026